Recent Publications about MYCN
Gene Database Entries for MYCN (Cance GeneWeb)
MYCN Web Resources (Cance GeneWeb)
Back to NBL-PROF Home Page

Recent Publications

To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine. After viewing the abstract use your browser's [Back] button to return to this page.

Nguyen T, et al. Combined RARalpha- and RXR-specific ligands overcome N-myc-associated retinoid resistance in neuroblastoma cells. Biochem Biophys Res Commun 2003 Mar 14;302(3):462-8    [Related articles]

Misawa A, et al. Rapamycin inhibits proliferation of human neuroblastoma cells without suppression of MycN. Int J Cancer 2003 Mar 20;104(2):233-7    [Related articles]

Vandesompele J, et al. ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value. Oncogene 2003 Jan 23;22(3):456-60    [Related articles]

Noguera R, et al. MYCN gain and MYCN amplification in a stage 4S neuroblastoma. Cancer Genet Cytogenet 2003 Jan 15;140(2):157-61    [Related articles]

Wittrock J, et al. Induction of N-myc in neuroblastoma by autocrine IGF-II depends on farnesylated Ras. Application of farnesyltransferase inhibitors. Anticancer Res 2002 Nov-Dec;22(6C):4205-9    [Related articles]

Valent A, et al. MYCN gene overrepresentation detected in primary neuroblastoma tumour cells without amplification. J Pathol 2002 Dec;198(4):495-501    [Related articles]

Ribatti D, et al. In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression. Int J Cancer 2002 Dec 1;102(4):351-4    [Related articles]

Strieder V, et al. E2F proteins regulate MYCN expression in neuroblastomas. J Biol Chem 2002 Nov 15; [epub ahead of print]    [Related articles]

Kaneko M, et al. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification. J Pediatr Hematol Oncol 2002 Nov;24(8):613-21    [Related articles]

Brodeur GM. Commentary on Kaneko et al.: Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification. J Pediatr Hematol Oncol 2002 Nov;24(8):608-9    [Related articles]

Zhu X, et al. N-myc Modulates Expression of p73 in Neuroblastoma. Neoplasia 2002 Sep-Oct;4(5):432-9    [Related articles]

Zhu X, et al. N-myc Modulates Expression of p73 in Neuroblastoma. Neoplasia 2002 Sep-Oct;4(5):432-9    [Related articles]

Sun L, et al. Antisense peptide nucleic acids conjugated to somatostatin analogs and targeted at the n-myc oncogene display enhanced cytotoxity to human neuroblastoma IMR32 cells expressing somatostatin receptors. Peptides 2002 Sep;23(9):1557    [Related articles]

Lillington DM, et al. High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours. Br J Cancer 2002 Sep 23;87(7):779-82    [Related articles]

Kushner BH, et al. Chronic neuroblastoma. Cancer 2002 Sep 15;95(6):1366-75    [Related articles]

Inge TH, et al. Importance of Sp1 consensus motifs in the MYCN promoter. Surgery 2002 Aug;132(2):232-8    [Related articles]

Hatzi E, et al. N-myc oncogene overexpression down-regulates leukemia inhibitory factor in neuroblastoma. Eur J Biochem 2002 Aug;269(15):3732-41    [Related articles]

Hatzi E, et al. N-myc oncogene overexpression down-regulates leukemia inhibitory factor in neuroblastoma. Eur J Biochem 2002 Aug;269(15):3732-41    [Related articles]

Cho JG, et al. Pharmacokinetics of (111)In-labeled triplex-forming oligonucleotide targeting human N-myc gene. Mol Cells 2002 Aug 31;14(1):93-100    [Related articles]

Noujaim D, et al. N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells. Oncogene 2002 Jul 4;21(29):4549-57    [Related articles]

Combaret V, et al. Circulating MYCN DNA as a Tumor-specific Marker in Neuroblastoma Patients. Cancer Res 2002 Jul 1;62(13):3646-8    [Related articles]

Schwab M. Amplified MYCN in human neuroblastoma: paradigm for the translation of molecular genetics to clinical oncology. Ann N Y Acad Sci 2002 Jun;963:63-73    [Related articles]

Mora J, et al. Evolving significance of prognostic markers associated with treatment improvement in patients with stage 4 neuroblastoma. Cancer 2002 May 15;94(10):2756-65    [Related articles]     Chromosome 1p Chromosome 17q

Hatzi E, et al. N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth. Oncogene 2002 May 16;21(22):3552-61    [Related articles]

Toffolatti L, et al. MYCN expression in human rhabdomyosarcoma cell lines and tumour samples. J Pathol 2002 Apr;196(4):450-8    [Related articles]

Melegh Z, et al. Detection of n-myc gene amplification in neuroblastoma using polymerase chain reaction based methods [Hungarian] Magy Onkol 2002 Apr 30;46(1):43-8    [Related articles]

Teitz T, et al. Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN. Oncogene 2002 Mar 14;21(12):1848-58    [Related articles]     Chromosome 1p

Godfried MB, et al. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. Oncogene 2002 Mar 27;21(13):2097-101    [Related articles]     Chromosome 17q

Wartiovaara K, et al. N-myc Promotes Survival and Induces S-Phase Entry of Postmitotic Sympathetic Neurons. J Neurosci 2002 Feb 1;22(3):815-24    [Related articles]

Shohet JM, et al. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma. Cancer Res 2002 Feb 15;62(4):1123-8    [Related articles]

Krams M, et al. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification. Cancer 2002 Feb 1;94(3):854-61    [Related articles]

Kerbl R, et al. Neuroblastoma with focal MYCN amplification and bone marrow infiltration: a staging and treatment dilemma. Med Pediatr Oncol 2002 Feb;38(2):109-11    [Related articles]

De Preter K, et al. Quantification of MYCN, DDX1, and NAG Gene Copy Number in Neuroblastoma Using a Real-Time Quantitative PCR Assay. Mod Pathol 2002 Feb;15(2):159-66    [Related articles]

Lasorella A, et al. Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma. Cancer Res 2002 Jan 1;62(1):301-6    [Related articles]

Ross RA, et al. Glucocorticoids induce neuroendocrine cell differentiation and increase expression of N-myc in N-type human neuroblastoma cells. Oncol Res 2002;13(2):87-94    [Related articles]

Manohar CF, et al. HuD, a neuronal-specific RNA-binding protein, increases the in vivo stability of MYCN mRNA. J Biol Chem 2001 Nov 15; [epub ahead of print]    [Related articles]

Goto S, et al. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors. Cancer 2001 Nov 15;92(10):2699-2708    [Related articles]

McConville CM, et al. Molecular cytogenetic characterization of two non-MYCN amplified neuroblastoma cell lines with complex t(11;17). Cancer Genet Cytogenet 2001 Oct 15;130(2):133-40    [Related articles]

Sato Y, et al. Expression of the cdc25B mRNA Correlated with that of N-myc in Neuroblastoma. Jpn J Clin Oncol 2001 Sep;31(9):428-31    [Related articles]

Bannasch D, et al. Functional interaction of Yaf2 with the central region of MycN. Oncogene 2001 Sep 13;20(41):5913-9    [Related articles]

Luttikhuis ME, et al. Neuroblastomas with chromosome 11q loss and single copy MYCN comprise a biologically distinct group of tumours with adverse prognosis. Br J Cancer 2001 Aug 17;85(4):531-7    [Related articles]

Jasty R, et al. Bcl-2 and n-myc coexpression increases igf-ir and features of malignant growth in neuroblastoma cell lines. Neoplasia 2001 Jul-Aug;3(4):304-13    [Related articles]

Anderson J, et al. Neuroblastoma in monozygotic twins--a case of probable twin-to-twin metastasis. Br J Cancer 2001 Aug 17;85(4):493-6    [Related articles]     Chromosome 1p

Sasaki H, et al. Expression of the prothymosin alpha mRNA correlated with that of N-myc in neuroblastoma. Cancer Lett 2001 Jul 26;168(2):191-5    [Related articles]

Tweddle DA, et al. p53 Cellular localization and function in neuroblastoma : evidence for defective g(1) arrest despite waf1 induction in mycn-amplified cells. Am J Pathol 2001 Jun;158(6):2067-77    [Related articles]

Lastowska M, et al. Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors. J Clin Oncol 2001 Jun 15;19(12):3080-90    [Related articles]     Chromosome 1p Chromosome 17q

Chen B, et al. Rearrangement in the coding region of the mycn gene in a subset of amplicons in a case of neuroblastoma with mycn amplification. Diagn Mol Pathol 2001 Jun;10(2):100-4    [Related articles]

Valent A, et al. In vivo elimination of acentric double minutes containing amplified MYCN from neuroblastoma tumor cells through the formation of micronuclei. Am J Pathol 2001 May;158(5):1579-84    [Related articles]

Bergmann E, et al. Expression of P27(KIP1) is prognostic and independent of MYCN amplification in human neuroblastoma. Int J Cancer 2001 May 20;95(3):176-83    [Related articles]

Mathew P, et al. Detection of mycn gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study. Neoplasia 2001 Mar-Apr;3(2):105-9    [Related articles]

Iyengar RV, et al. Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression. Cancer Res 2001 Apr 1;61(7):3045-52    [Related articles]

Dufner-Beattie J, et al. Retinoic acid-induced expression of autotaxin in N-myc-amplified neuroblastoma cells. Mol Carcinog 2001 Apr;30(4):181-9    [Related articles]

Rossler J, et al. Hypoxia Promotes Apoptosis of Human Neuroblastoma Cell Lines with Enhanced N-myc Expression. Biochem Biophys Res Commun 2001 Feb 23;281(2):272-276    [Related articles]

Fan L, et al. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells. Cancer Res 2001 Feb 1;61(3):1073-9    [Related articles]

Wimmer K, et al. Two-dimensional DNA electrophoresis identifies novel CpG islands frequently coamplified with MYCN in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):75-9    [Related articles]

Wittke I, et al. DAP-5 is involved in MycN/IFNgamma-induced apoptosis in human neuroblastoma cells. Cancer Lett 2001 Jan 26;162(2):237-243    [Related articles]

Vandesompele J, et al. Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic subgroups are there? Med Pediatr Oncol 2001 Jan;36(1):5-10    [Related articles]     Chromosome 1p Chromosome 17q

Tang XX, et al. Association among EPHB2, TrkA, and MYCN expression in low-stage neuroblastomas. Med Pediatr Oncol 2001 Jan;36(1):80-2    [Related articles]

O'Neill S, et al. MYCN amplification and 17q in neuroblastoma: Evidence for structural association. Genes Chromosomes Cancer 2001 Jan;30(1):87-90    [Related articles]     Chromosome 17q

Ladenstein R, et al. Prognostic significance of DNA di-tetraploidy in neuroblastoma. Med Pediatr Oncol 2001 Jan;36(1):83-92    [Related articles]     Chromosome 1p

George RE, et al. Relationship between histopathological features, MYCN amplification, and prognosis: a UKCCSG study. United Kingdom Children Cancer Study Group. Med Pediatr Oncol 2001 Jan;36(1):169-76    [Related articles]

Ambros PF, et al. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Med Pediatr Oncol 2001 Jan;36(1):1-4    [Related articles]     Chromosome 1p

Ambros PF, et al. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Med Pediatr Oncol 2001 Jan;36(1):1-4    [Related articles]     Chromosome 1p

Suita S, et al. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification. J Pediatr Surg 2000 Dec;35(12):1737-1741    [Related articles]

Schmidt ML, et al. Differential expression in an antisense MYCN neuroblastoma model. Med Pediatr Oncol 2000 Dec 1;35(6):669-672    [Related articles]

Norris MD, et al. Expression of N-myc and MRP genes and their relationship to N-myc gene dosage and tumor formation in a murine neuroblastoma model. Med Pediatr Oncol 2000 Dec 1;35(6):585-589    [Related articles]

Hogarty MD, et al. BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification. Med Pediatr Oncol 2000 Dec 1;35(6):559-562    [Related articles]

Fulda S, et al. MycN sensitizes neuroblastoma cells for drug-triggered apoptosis. Med Pediatr Oncol 2000 Dec 1;35(6):582-584    [Related articles]

Eggert A, et al. Different effects of TrkA expression in neuroblastoma cell lines with or without MYCN amplification. Med Pediatr Oncol 2000 Dec 1;35(6):623-627    [Related articles]

Matthay KK MYCN Expression in Neuroblastoma: A Mixed Message? J Clin Oncol 2000 Nov 1;18(21):3591-3594    [Related articles]

Gross N, et al. MYCN-Related Suppression of Functional CD44 Expression Enhances Tumorigenic Properties of Human Neuroblastoma Cells. Exp Cell Res 2000 Nov 1;260(2):396-403    [Related articles]

Cohn SL, et al. MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN. J Clin Oncol 2000 Nov 1;18(21):3604-3613    [Related articles]

Minard V, et al. Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology. Br J Cancer 2000 Oct;83(8):973-979    [Related articles]     Trials & Studies

Mac SM, et al. Direct recruitment of N-myc to target gene promoters. Mol Carcinog 2000 Oct;29(2):76-86    [Related articles]

Breit S, et al. N-myc down-regulates activin A. Biochem Biophys Res Commun 2000 Aug 2;274(2):405-9    [Related articles]

Breit S, et al. The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. Cancer Res 2000 Aug 15;60(16):4596-601    [Related articles]

Alvarado CS, et al. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study. J Pediatr Hematol Oncol. 2000 May-Jun;22(3):197-205.    [Related articles]

Teitz T, et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med. 2000 May;6(5):529-35.    [Related articles]

Sarkar AK, et al. Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes. Cancer Res. 2000 Apr 1;60(7):1908-13.    [Related articles]

Schmidt ML, et al. Biologic Factors Determine Prognosis in Infants With Stage IV Neuroblastoma: A Prospective Children's Cancer Group Study. J Clin Oncol. 2000 Mar;18(6):1260-1268.    [Related articles]

Oude Luttikhuis ME, et al. Detection of MYCN amplification in neuroblastoma using competitive PCR quantitation. Lab Invest. 2000 Feb;80(2):271-3.    [Related articles]

Misawa A, et al. N-Myc induction stimulated by insulin-like growth factor I through mitogen-activated protein kinase signaling pathway in human neuroblastoma cells. Cancer Res. 2000 Jan 1;60(1):64-9.    [Related articles]

Freeman-Edward J, et al. Expulsion of amplified MYCN from neuroblastoma tumor cells Cancer Genet Cytogenet. 2000 Jan 1;116(1):87-8    [Related articles]

Hatzi E, et al. MYCN oncogene and angiogenesis: down-regulation of endothelial growth inhibitors in human neuroblastoma cells. Purification, structural, and functional characterization. Adv Exp Med Biol 2000;476:239-48    [Related articles]

Yoshimoto M, et al. MYCN gene amplification : identification of cell populations containing double minutes and Homogeneously staining regions in neuroblastoma tumors. Am J Pathol. 1999 Nov;155(5):1439-43.    [Related articles]

Tajiri T, et al. Highly sensitive analysis for N-myc amplification in neuroblastoma based on fluoresence in situ hybridization. J Pediatr Surg. 1999 Nov;34(11):1615-9.    [Related articles]

Raggi CC, et al. Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system. Clin Chem. 1999 Nov;45(11):1918-24.    [Related articles]

Bannasch D, et al. Nmi protein interacts with regions that differ between MycN and Myc and is localized in the cytoplasm of neuroblastoma cells in contrast to nuclear MycN. Oncogene. 1999 Nov 18;18(48):6810-7.    [Related articles]

Kawa K, et al. Long-Term Survivors of Advanced Neuroblastoma With MYCN Amplification: A Report of 19 Patients Surviving Disease-Free for More Than 66 Months. J Clin Oncol. 1999 Oct;17(10):3216-3220.    [Related articles]

Tai KF, et al. Definition of the human N-myc promoter region during development in a transgenic mouse model. Pediatr Res. 1999 Sep;46(3):255-62.    [Related articles]

Guo C, et al. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene. 1999 Sep 2;18(35):4948-57.    [Related articles]

Fotsis T, et al. Down-regulation of endothelial cell growth inhibitors by enhanced MYCN oncogene expression in human neuroblastoma cells. Eur J Biochem. 1999; 263(3):757-64.    [Related articles]

Raschella G, et al. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification. Cancer Res. 1999 ;59(14):3365-8.    [Related articles]

Hasan Z, et al. Competitive polymerase chain reaction for the determination of N-myc amplification in neuroblastoma: report of clinical cases. Eur J Pediatr Surg. 1999 Jun;9(3):138-41.    [Related articles]

Chambery D, et al. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line. Cancer Res. 1999 Jun 15;59(12):2898-902.    [Related articles]

Lazarova DL, et al. HuD, a neuronal-specific RNA-binding protein, is a putative regulator of N-myc pre-mRNA processing/stability in malignant human neuroblasts. Oncogene. 1999 Apr 29;18(17):2703-10.    [Related articles]

Haber M, et al. Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells. Oncogene. 1999 Apr 29;18(17):2777-82.    [Related articles]

Galderisi U, et al. Differentiation and apoptosis of neuroblastoma cells: role of N-myc gene product. J Cell Biochem. 1999 Apr 1;73(1):97-105.    [Related articles]

Akiyama K, et al. Expression of two dead box genes (DDX1 and DDX6) is independent of that of MYCN in human neuroblastoma cell lines. Biochem Mol Biol Int. 1999 Apr;47(4):563-8.    [Related articles]

Yang HW, et al. Development of a polyclonal antibody with defined specificity against synthetic peptides from the N-myc oncoprotein using multiple antigen peptide and hemocyanin conjugation methods. J Pediatr Surg. 1999 Mar;34(3):454-60.    [Related articles]

Hiyama E, et al. Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma. Clin Cancer Res. 1999 Mar;5(3):601-9.    [Related articles]

Hogarty MD, et al. Wild-type sequence of MYCN in neuroblastoma cell lines. Int J Cancer. 1999 Feb 9;80(4):630-1.    [Related articles]

Fulda S, et al. MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene. 1999 Feb 18;18(7):1479-86.    [Related articles]

Yang HW, et al. A polyclonal antibody against synthetic peptide conserved in N-Myc protein reacts with water-soluble recombinant N-Myc protein. Oncol Rep. 1999 Jan;6(1):107-111.    [Related articles]

Wimmer K, et al. Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma. Oncogene. 1999 Jan 7;18(1):233-8.    [Related articles]

Sivak LE, et al. A novel intron element operates posttranscriptionally To regulate human N-myc expression. Mol Cell Biol. 1999 Jan;19(1):155-63.    [Related articles]

Zaizen Y, et al. The role of cellular motility in the invasion of human neuroblastoma cells with or without N-myc amplification and expression. J Pediatr Surg. 1998 Dec;33(12):1765-70.    [Related articles]

Komuro H, et al. Fluorescence in situ hybridization analysis of chromosome 1p36 deletions in human MYCN amplified neuroblastoma. J Pediatr Surg. 1998 Nov;33(11):1695-8.    [Related articles]     Chromosome 1p

Garcia de Veas R, et al. Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein. Eur J Cancer. 1998 Oct;34(11):1736-40.    [Related articles]

Bordow SB, et al. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J Clin Oncol. 1998 Oct;16(10):3286-94. Review.    [Related articles]

Taga T, et al. An infant with neuroblastoma and MYCN amplification found through mass screening. J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):486-8.    [Related articles]     Screening

Godbout R, et al. Overexpression of a DEAD Box Protein (DDX1) in Neuroblastoma and Retinoblastoma Cell Lines. J Biol Chem 1998 Aug 14;273(33):21161-21168    [Related articles]

Lutz W, et al. MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells. Oncogene 1998 Jul 23;17(3):339-346    [Related articles]

Kaneko M, et al. Stratification of treatment of stage 4 neuroblastoma patients based on N-myc amplification status. Study Group of Japan for Treatment of Advanced Neuroblastoma, Tokyo, Japan. Med Pediatr Oncol 1998 Jul;31(1):1-7    [Related articles]     Trials & Studies

Ben-Yosef T, et al. Involvement of Myc targets in c-myc and N-myc induced human tumors. Oncogene 1998 Jul 16;17(2):165-171    [Related articles]

Katzenstein HM, et al. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the Pediatric Oncology Group experience. J Clin Oncol. 1998 Jun; 16(6): 2007-2017.    [Related articles]

Brown A, et al. Genistein modulates neuroblastoma cell proliferation and differentiation through induction of apoptosis and regulation of tyrosine kinase activity and N-myc expression. Carcinogenesis 1998 Jun;19(6):991-997    [Related articles]

Santiago LR, et al. AF64A-induced changes in N-myc expression in the LA-N-2 human neuroblastoma cell line are modulated by choline and hemicholinium-3. Neurochem Res. 1998 May;23(5):743-50.    [Related articles]

Kavallaris M, et al. In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells. Anticancer Res. 1998 May-Jun;18(3A):1793-7.    [Related articles]

Gotoh T, et al. Human neuroblastoma demonstrating clonal evolution in vivo. Genes Chromosomes Cancer. 1998 May;22(1):42-9.    [Related articles]     Chromosome 1p

Savini I, et al. Ascorbic acid recycling in N-myc amplified human neuroblastoma cells. Anticancer Res. 1998 Mar-Apr;18(2A):819-22.    [Related articles]

Gallego S, et al. Differential polymerase chain reaction with serial dilutions for quantification of MYCN gene amplification in neuroblastoma. Anticancer Res. 1998 Mar-Apr;18(2A):1211-5.    [Related articles]

Bonvini P, et al. In vivo degradation of N-myc in neuroblastoma cells is mediated by the 26S proteasome. Oncogene. 1998 Mar 5;16(9):1131-9.    [Related articles]

Wada RK, et al. Interferon-gamma and retinoic acid down-regulate N-myc in neuroblastoma through complementary mechanisms of action. Cancer Lett. 1997 Dec 23;121(2):181-8.    [Related articles]

Ross RA, et al. HuD, a neuronal-specific RNA-binding protein, is a potential regulator of MYCN expression in human neuroblastoma cells. Eur J Cancer. 1997 Oct;33(12):2071-4.    [Related articles]

Kramer K, et al. Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma. Eur J Cancer. 1997 Oct;33(12):2098-100.    [Related articles]

Combaret V, et al. Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma. Eur J Cancer. 1997 Oct;33(12):2101-5.    [Related articles]

Chagnovich D, et al. Activity of a 40 kDa RNA-binding protein correlates with MYCN and c-fos mRNA stability in human neuroblastoma. Eur J Cancer. 1997 Oct;33(12):2064-7.    [Related articles]

Chan HSL, et al. MYCN Protein Expression as a Predictor of Neuroblastoma Prognosis. Clin Cancer Res. 1997 Oct;3(10):1699-1706.    [Related articles]

Montanaro L, et al. N-myc amplification and cell proliferation rate in human neuroblastoma. Eur J Histochem. 1997;41 Suppl 2:141-2.    [Related articles]

Squire JA, et al. Identification of MYCN Copy Number Heterogeneity by Direct FISH Analysis of Neuroblastoma Preparations. Mol Diagn. 1996 Dec;1(4):281-289.    [Related articles]

Chen J, et al. [Effects of antisense N-myc gene on nerve growth factor-induced differentiation of neuroblastoma cell line] Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1999 Jun;21(3):197-202    [Related articles]

Kong XT, et al. Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines. Neoplasia 1999 Apr;1(1):80-9    [Related articles]

Tornoczky T, et al. [Competitive polymerase chain reaction: a new method for measuring N-myc amplification]. Orv Hetil. 2000 Jan 2;141(1):27-30. Hungarian.    [Related articles]

Schwab M MYCN Amplification in Neuroblastoma: a Paradigm for the Clinical Use of an Oncogene. Pathol Oncol Res 1997;3(1):3-7    [Related articles]

Pawlik CA, et al. Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells to CPT-11. Mol Ther 2000 May;1(5 Pt 1):457-63    [Related articles]

Matthay KK, et al. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. J Clin Oncol 1998 Apr;16(4):1256-64      Trials & Studies

Related Resources

Search PUBMED for "TITLE: neuroblastoma AND (mycn OR n-myc)"
(National Library of Medicine, USA)
Molecular Biology Databases (Guide to Internet Resources for Cancer)
Web Resources about Neuroblastoma (Children's Cancer Web)

Back to NBL-PROF Home Page